These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29800622)

  • 1. Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.
    Wolitzky-Taylor K; Niles AN; Ries R; Krull JL; Rawson R; Roy-Byrne P; Craske M
    Behav Res Ther; 2018 Aug; 107():1-9. PubMed ID: 29800622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.
    Wolitzky-Taylor K; Drazdowski TK; Niles A; Roy-Byrne P; Ries R; Rawson R; Craske MG
    Behav Res Ther; 2018 Aug; 107():34-41. PubMed ID: 29852309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.
    Wolitzky-Taylor K; Krull J; Rawson R; Roy-Byrne P; Ries R; Craske MG
    J Consult Clin Psychol; 2018 Jan; 86(1):81-88. PubMed ID: 29300100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.
    Craske MG; Stein MB; Sullivan G; Sherbourne C; Bystritsky A; Rose RD; Lang AJ; Welch S; Campbell-Sills L; Golinelli D; Roy-Byrne P
    Arch Gen Psychiatry; 2011 Apr; 68(4):378-88. PubMed ID: 21464362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
    Kelly JM; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy.
    Campbell-Sills L; Roy-Byrne PP; Craske MG; Bystritsky A; Sullivan G; Stein MB
    Depress Anxiety; 2016 Dec; 33(12):1099-1106. PubMed ID: 27775823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial.
    Campbell-Sills L; Sherbourne CD; Roy-Byrne P; Craske MG; Sullivan G; Bystritsky A; Lang AJ; Chavira DA; Rose RD; Shaw Welch S; Stein MB
    J Clin Psychiatry; 2012 Dec; 73(12):1509-16. PubMed ID: 23290323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial.
    van Emmerik-van Oortmerssen K; Vedel E; Kramer FJ; Blankers M; Dekker JJM; van den Brink W; Schoevers RA
    Drug Alcohol Depend; 2019 Apr; 197():28-36. PubMed ID: 30769263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an integrated group cognitive-behavioral treatment for comorbid mood, anxiety, and substance use disorders: A pilot study.
    Milosevic I; Chudzik SM; Boyd S; McCabe RE
    J Anxiety Disord; 2017 Mar; 46():85-100. PubMed ID: 27568875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care.
    Wolitzky-Taylor K; Brown LA; Roy-Byrne P; Sherbourne C; Stein MB; Sullivan G; Bystritsky A; Craske MG
    J Anxiety Disord; 2015 Mar; 30():88-93. PubMed ID: 25615523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.
    Roy-Byrne P; Craske MG; Sullivan G; Rose RD; Edlund MJ; Lang AJ; Bystritsky A; Welch SS; Chavira DA; Golinelli D; Campbell-Sills L; Sherbourne CD; Stein MB
    JAMA; 2010 May; 303(19):1921-8. PubMed ID: 20483968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy.
    Wolitzky-Taylor KB; Arch JJ; Rosenfield D; Craske MG
    J Consult Clin Psychol; 2012 Oct; 80(5):786-99. PubMed ID: 22823858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care.
    Joesch JM; Sherbourne CD; Sullivan G; Stein MB; Craske MG; Roy-Byrne P
    Psychol Med; 2012 Sep; 42(9):1937-48. PubMed ID: 22152230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term intensive psychodynamic group therapy versus cognitive-behavioral group therapy in day treatment of anxiety disorders and comorbid depressive or personality disorders: study protocol for a randomized controlled trial.
    Suszek H; Holas P; Wyrzykowski T; Lorentzen S; Kokoszka A
    Trials; 2015 Jul; 16():319. PubMed ID: 26220089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age differences in treatment response to a collaborative care intervention for anxiety disorders.
    Wetherell JL; Petkus AJ; Thorp SR; Stein MB; Chavira DA; Campbell-Sills L; Craske MG; Sherbourne C; Bystritsky A; Sullivan G; Roy-Byrne P
    Br J Psychiatry; 2013 Jul; 203(1):65-72. PubMed ID: 23580378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Randomized Clinical Trial.
    Weersing VR; Brent DA; Rozenman MS; Gonzalez A; Jeffreys M; Dickerson JF; Lynch FL; Porta G; Iyengar S
    JAMA Psychiatry; 2017 Jun; 74(6):571-578. PubMed ID: 28423145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial.
    Schäfer I; Chuey-Ferrer L; Hofmann A; Lieberman P; Mainusch G; Lotzin A
    BMC Psychiatry; 2017 Mar; 17(1):95. PubMed ID: 28302084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study.
    Brown LA; Krull JL; Roy-Byrne P; Sherbourne CD; Stein MB; Sullivan G; Rose RD; Bystritsky A; Craske MG
    Psychol Med; 2015 Feb; 45(3):647-61. PubMed ID: 25272965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.